Dermata Therapeutics Entered Into ATM Agreement With H.C. Wainwright Providing For Sale By Co Of $1.2M Of Its Shares Of Common Stock From Time To Time
Portfolio Pulse from Benzinga Newsdesk
Dermata Therapeutics has entered into an At-The-Market (ATM) agreement with H.C. Wainwright, allowing the sale of up to $1.2 million of its common stock over time.
June 07, 2024 | 9:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dermata Therapeutics has entered into an ATM agreement with H.C. Wainwright, allowing the sale of up to $1.2 million of its common stock over time. This could lead to potential dilution of existing shares.
The ATM agreement allows Dermata Therapeutics to sell additional shares, which could dilute the value of existing shares. This is likely to have a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100